Omicron: Pfizer-BioNTech COVID-19 vaccine may only partially protect against new variant, study suggests
December 09 2021, 08:00
A new study led by the Africa Health Research Institute reportedly suggests that the omicron COVID-19 variant escapes antibody immunity induced by two doses of the Pfizer-BioNTech vaccine.
A new study led by the Africa Health Research Institute reportedly suggests that the omicron COVID-19 variant escapes antibody immunity induced by two doses of the Pfizer-BioNTech vaccine.
Source:
FOX News